FloridaMarijuana.net

JUNE 13, 2018

For centuries, humans have relied on the cannabis plant for its therapeutic properties. More than ever, cannabis can aid in the treatment of chronic disease and as a supplement to cancer treatments. Cannabis has given cancer patients relief , improved their mood and anxiety, and relieved insomnia.

Clinical Trials 189

Clinical Trials Marijuana Patients Chronic Pain 189

Cannabis Law Report

OCTOBER 5, 2021

Systematic literature review of the therapeutic value, benefits and risks of MDMA and psilocybin for the treatment of mental health conditions. An evaluation of the therapeutic value, benefits and risks of methylenedioxymethamphetamine (MDMA) and psilocybin for the treatment of mental, behavioural or developmental disorders.

Treatment 52

Treatment Conditions Medicine Clinical Trials 52

The Cannigma

JANUARY 18, 2022

It’s not often that cannabis takes mainstream news by storm, but a recent study about cannabis compounds and COVID-19 did just that. Cue media freakout. They then tried to infect human cells with the virus, which they found was prevented by the presence of certain compounds produced by the cannabis plant.

Cannabinoids 120

Cannabinoids Concentrates Dispensary CBD 120

The Cannigma

MAY 5, 2021

This line from “Jurassic Park” may come to mind when you hear the words “snortable cannabis,” but it’s perhaps not quite the horror show you may think. It was billed as a “unique cannabis concentrate,” and that may be putting it lightly. What is snortable cannabis? What exactly is powdered cannabis?

Cannabinoids 145

Cannabinoids Cannabis Edibles THC 145

Cannabis Law Report

DECEMBER 22, 2021

With growing interest in sustainable and bio-based cannabinoids, and after completing a strategic review of Hyasynth including their intellectual property (IP) and R&D platforms, Organigram remains excited about Hyasynth’s future and growth plans. NASDAQ: OGI), (TSX: OGI), the parent company of Organigram Inc. million in October 2020.

Cannabinoids 52

Cannabinoids Research and Development Events Pharmaceutical 52

MMJ Recs

DECEMBER 22, 2023

As the United States navigates through a complex web of legal, social, and medical considerations, public opinion on medical cannabis has evolved significantly over the years. The changing public opinion is evident in the increasing number of states legalizing medical cannabis and the growing support for such measures.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

JULY 28, 2021

Cannabis Patient Care™ launched in November 2020 and has already made a big impression in the medical cannabis community due to the quality of its content and the important message behind each issue,” said Mike Hennessy Jr.

Access 105

Access Patients Education Treatment 105

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. billion 1 by 2025.

Access 105

Access Research and Development Pharmaceutical Therapy 105

MMJ Recs

NOVEMBER 24, 2023

With a growing number of medical cannabis dispensaries across the state, Virginians are gaining access to an array of MMJ strains and products that cater to their specific needs. These strains are cultivated to contain specific levels of cannabinoids, including THC and CBD, to address different health needs.

Strains 52

Strains Chronic Pain Indica Patients 52

The Cannigma

MAY 19, 2021

Medical : Illegal Recreational : Illegal *CBD products are legal in Japan, as long as they contain no THC whatsoever and are not made from cannabis flower. Japan is known for its world-leading innovations, technology, and design, but when it comes to cannabis, the island nation remains decidedly regressive. But in modern times?

Law 137

Law Legalization Clinical Trials CBD 137

Cannabis Law Report

JUNE 30, 2021

LONDON–(BUSINESS WIRE)– Fourfive , the CBD and nutrition brand loved by athletes and those leading an active lifestyle, today called on the UK’s sports governing bodies to stop sitting if on the fence and conduct clinical trials into the effectiveness of CBD and medicinal cannabis in professional sport. fourfive.com.

Medicine 75

Medicine Clinical Trials CBD Sleep 75

Cannabis Law Report

AUGUST 17, 2021

RLS103 is being developed for the treatment of performance anxiety in patients with social anxiety disorder (SAD), and acute panic in patients with panic disorder. Currently, there are no FDA approved treatment options available for these patients.”. Email: media@receptorlife.com. David Sheon. 202 422-6999.

CBD 98

CBD Research and Development Pharmaceutical Therapy 98

MMJ Recs

FEBRUARY 29, 2024

The landscape of medical marijuana has evolved, offering patients alternative avenues for accessing therapeutic cannabis. In Florida, licensed Medical Marijuana Treatment Centers (MMTCs) are authorized to cultivate, process, and dispense medical marijuana to qualified patients.

Cultivation 52

Cultivation Marijuana Environment Patients 52

Veriheal

OCTOBER 1, 2020

All over the world, governments are moving towards legalizing or at least decriminalizing, cannabis. African, Asian, American, European, and other countries have all been following the global cannabis movement, whether for recreational or medicinal purposes. When we speak of the UK, think England, Scotland, Wales, and Northern Ireland.

Legalization 104

Legalization Oil Medicine Media 104

The Cannigma

JULY 1, 2022

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. These claims influence things like how consumers purchase cannabis or how doctors consult with medical cannabis patients. The cannabis problem.

Research and Development 108

Research and Development Data THC Clinical Trials 108

MassRoots

JANUARY 9, 2019

The use of topical cannabis products to treat symptoms of psoriasis and arthritis, or to help reduce localized pain and inflammation is a relatively new concept in modern medicine. Posting about Carter’s experience on popular social media sites brought them a tip from a helpful stranger who found relief using cannabis infused shampoo.

Topical 87

Topical Media Oil Cannabis 87

Veriheal

MAY 17, 2021

There are 36 states in the United States that have chosen the legalization of medical cannabis for residents of their states. Many of them even offer the ability for visiting medical cannabis patients from other states to participate in their programs. District Attorneys Believe Medical Cannabis is a Lie.

Legalization 93

Legalization Pharmaceutical Therapy Chronic Pain 93

Alchimia

MARCH 16, 2016

Although a balanced nutrition – and regular brain stimulation – can have protective and preventive effects , we still don’t have any effective treatment for Alzheimer’s disease once it is active. How does cannabis combat Alzheimer’s disease? Cannabis patient. They actually protect our neurons!

Cannabinoids 76

Cannabinoids Research and Development Treatment Patients 76

MMJ Recs

JANUARY 13, 2024

Patients seeking relief from various ailments are increasingly turning to specific cannabis strains renowned for their therapeutic properties. The realm of MMJ is expanding rapidly, with various types becoming the most popular MMJ strains due to their unique combinations of cannabinoids and terpenes.

Strains 52

Strains Chronic Pain Indica Sativa 52

Cannabis Law Report

FEBRUARY 11, 2020

The hunger for knowledge and cannabis education exceeds the willingness of physicians to prescribe cannabis to patients according to a Shoppers Drug Mart survey. Millennials might be the top consumers of cannabis in Canada, but their older age cohorts the zoomers lead the way in consuming cannabis for health and wellness benefits.

Education 59

Education Treatment Media Recreational 59

CannaMD

MAY 19, 2020

In a working draft of research prepared by Canadian scientists, study authors claim that their findings are “crucial for the future analysis of the effects of medical cannabis on COVID-19.” And then something interesting happened: Serendipitously, we noted that cannabis may also affect ACE2. COVID-19 Basics: ACE2.

Research and Development 131

Research and Development Sativa Marijuana Extraction 131

CannaMD

AUGUST 19, 2020

Can cannabis help treat the coronavirus? CannaMD takes a look at everything we know about cannabis and COVID-19 so far – separating science from spectacle, and highlighting key findings that might even surprise the most seasoned medical marijuana supporters. Marijuana cannabinoid, CBD. Coronavirus Basics.

Research and Development 141

Research and Development Marijuana Extraction Terpenes 141

SpeedWeed

AUGUST 3, 2021

Sativex, the cannabis oral spray, has been chosen to be used in an upcoming study in treating an aggressive type of cancer known as glioblastoma. so it may enhance the effects of chemotherapy treatment in stopping these tumours growing, allowing patients to live longer. That is what we want to test in the study.” .

Treatment 71

Treatment Patients Medicine Media 71

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ will be utilizing its new products for an FDA approved treatment of multiple sclerosis (MS) and Huntington’s disease (HD). For media inquiries please contact: Michael Sharp.

DEA 66

DEA Clinical Trials THC Research and Development 66

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. Doctors can prescribe Epidyolex – an oral solution of cannabidiol, which comes from the cannabis plant – if they think it will help sufferers. What is Epidyolex?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Veriheal

JULY 2, 2020

Louisiana has had a medical cannabis program for many years. However, for patients to qualify for access to medical cannabis, they must have received a diagnosis of at least one of the 14 qualifying conditions that were initially approved under the initial law. The Bill as Passed. Now that the bill has been signed, as of August 1 st.,

Banking 52

Banking Programs Therapy Conditions 52

MMJ Recs

OCTOBER 5, 2023

With a growing number of MMJ dispensaries, a comprehensive set of laws, and a streamlined process for obtaining a medical marijuana card, the state has become a hub for patients seeking alternative treatments. These laws are designed to protect patients, provide access to treatment, and prevent abuse.

Dispensary 52

Dispensary Patients Treatment Conditions 52

Cannabis Info

SEPTEMBER 29, 2019

Cannabis & Dopamine: Link Reveals Both Risks & Hopes. The cannabis plant incorporates over 100 completely different cannabinoids, every interacting with the human mind in a particular method. The proof for a cannabinoid-dopamine link has been mounting for a while. Cannabinoids As ‘Anti-Psychotic’ Treatment.

Cannabinoids 45

Cannabinoids THC Cannabis CBD 45

MMJ Recs

JANUARY 22, 2024

In recent years, the landscape of medicinal cannabis has undergone a significant transformation, with an increasing focus on alternative consumption methods. This nuanced approach allows patients to customize their treatment, addressing specific symptoms or conditions without compromising mental clarity.

Edibles 52

Edibles Marijuana Chronic Pain THC 52

Cannabis Law Report

MAY 6, 2022

Since 2015, the FDA has sent warning letters to companies allegedly illegally selling unapproved cannabinoid (CBD) products. Customers’ only way to know the levels of cannabinoids and other ingredients these products contain is by reviewing labels, marketing claims, and checking certificates of analysis.

THC 52

THC CBD Media Food 52

Cannabis Law Report

NOVEMBER 16, 2019

Current barriers to patient access to medicinal cannabis in Australia. On 14 November 2019, the Senate referred an inquiry into the current barriers to patient access to medicinal cannabis in Australia to the Senate Community Affairs References Committee for inquiry and report by 12 February 2020. Media Releases. Track Inquiry.

Clinical Trials 58

Clinical Trials Access Medicine Patients 58

Cannabis Law Report

NOVEMBER 19, 2021

The most common treatment for insomnia is pharmaceutical drugs like Ambien or Lunesta, but these can come with dangerous side effects and even become addictive over time. CBD is a cannabinoid, which means it interacts with the body’s own endocannabinoid system to provide relief from a variety of different health conditions.

Sleep 52

Sleep CBD Oil Tincture 52

Cannabis Law Report

OCTOBER 14, 2021

TORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp. members will receive an exclusive 15 percent discount when they purchase any of the following Opticann CB4 medical cannabis products: CB4 Relief: Oral CBD Capsules with VESIsorb ® Technology. Opticann, a subsidiary of Heritage, to carry the trusted C.A.R.P.

Advocacy 52

Advocacy Research and Development Chronic Pain Pharmaceutical 52

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. Media Enquiries: Sam Brown Inc.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

SEPTEMBER 15, 2021

Delta-8 tetrahydrocannabinol, also known as delta-8 THC, is a psychoactive substance found in the Cannabis sativa plant, of which marijuana and hemp are two varieties. Delta-8 THC is one of over 100 cannabinoids produced naturally by the cannabis plant but is not found in significant amounts in the cannabis plant.

THC 105

THC Pets Events Hemp 105

Veriheal

AUGUST 12, 2021

million people across the United States , report experiencing improved quality of life and a more restful night’s sleep after consuming the non-psychoactive cannabinoid CBD (cannabidiol). In addition to this, the survey results featured responses from 138 patients who did not use any type of cannabis product. What is Artisanal CBD?

Epilepsy 81

Epilepsy Pharmaceutical Patients Sleep 81

Canna Law Blog

APRIL 22, 2020

In this global upheaval and opportunity seeking, cannabis is no exception. cannabis marketplace. cannabis markets. the current and future treatment of emerging cannabinoids beyond CBD such as CBG , CBN , and synthetic CBD. Some understand some of the nuances of the U.S., based operations and compete with U.S.

Supply Chain 53

Supply Chain Research and Development Hemp DEA 53